Status of nephrology off-label uses in the treatment of pediatrics

VernacularTitle:儿童肾病治疗中超说明书用药的现状
Author: Xin-Ran LI ¹ ; Shuang ZHOU ; Chao-Yang CHEN ; Ling-Yue MA ; Xu-Hui ZHONG ; Ying ZHOU ; Yi-Min CUI ; Jie DING
Author Information

1. 北京大学第一医院药剂科
Keywords: off-label use of drug; mycophenlate mofetil; tacrolimus; mizoribine; levamisole; rituximab
From: The Chinese Journal of Clinical Pharmacology 2018;34(7):887-890
CountryChina
Language:Chinese
Abstract: This paper retrieved an updated version of the kidney disease improving global outcomes (KDIGO) guideline and Chinese Medical Association guideline.By combining Micromedex given Thomson grade,we draw a evidence-based evaluation of off-label drug use in pediatric kidney disease.We concluded updated pediatric nephritic disease guidelines.Doctors and pharmacists should cause the attention,and regard off-label uses of drugs normatively and rationally.